Neuralstem’s NSI-566 stem cell therapy confers neurological improvement in spinal cord injury patients with complete … – GlobeNewswire (press release)
|
Neuralstem's NSI-566 stem cell therapy confers neurological improvement in spinal cord injury patients with complete …
GlobeNewswire (press release) Neuralstem Announces Publication of Data From First-In-Human Study of Human Neural Stem Cell Transplantation for Chronic Spinal Cord Injury -. – First cohort of four subjects with thoracic (T2-T12) ASIA-A grade spinal cord injury in the Phase I study … |
